Key result
Drug development for sedative hypnotics has been slow due to a market dominated by low-cost generics and a lack of new compounds that improve patient outcomes or justify development costs.
Why the study?
Drug development to support anaesthesia and sedation has been slow, with few candidates emerging from preclinical discovery and limited innovation beyond attempted reformulation of existing compounds.
Progress in sedative hypnotic drug development requires meaningful advances in basic science rather than minor reformulations of existing compounds.
May discourage new anaesthetic development without outcome gains; leaves open whether targeted reformulations can justify costs in generic-dominated markets.
PURPOSE OF REVIEW: Drug development to support anaesthesia and sedation has been slow with few candidates emerging from preclinical discovery and limited innovation beyond attempted reformulation of existing compounds. RECENT FINDINGS: The market is well supported by low-cost generic products and development compounds have not been shown to improve patient outcomes or possess other distinctive characteristics to justify the cost of development. SUMMARY: To make progress in a large-volume, low margin and highly competitive environment requires meaningful advances in relevant basic science. Opportunities exist, but probably require bolder initiatives than further attempts at reformulation or fiddling with the structure of propofol. Extending development ambitions to include nonanaesthesiologist providers challenges professional boundaries but may facilitate cost-effective changes in patterns of care.
No takes yet. Share an insight, caveat, or question.
J. Robert Sneyd (2024) conducted a review in Anaesthesia and sedation. Sedative hypnotics drug development was evaluated. Drug development for sedative hypnotics has been slow due to a market dominated by low-cost generics and a lack of new compounds that improve patient outcomes or justify development costs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: